Publications

Found 87 results
[ Author(Asc)] Title Type Year
Filters: Keyword is Male  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Morris NA, Merkler AE, Parker WE, Claassen J, E Connolly S, Sheth KN, Kamel H.  2016.  Adverse Outcomes After Initial Non-surgical Management of Subdural Hematoma: A Population-Based Study.. Neurocrit Care. 24(2):226-32.
Morris NA, Merkler AE, Gialdini G, Kamel H.  2017.  Timing of Incident Stroke Risk After Cervical Artery Dissection Presenting Without Ischemia.. Stroke. 48(3):551-555.
Milner TA, Chen RX, Welington D, Rubin BR, Contoreggi NH, Johnson MA, Mazid S, Marques-Lopes J, Marongiu R, Glass MJ.  2022.  Angiotensin II differentially affects hippocampal glial inflammatory markers in young adult male and female mice.. Learn Mem. 29(9):265-273.
Merkler AE, Reynolds AS, Gialdini G, Morris NA, Murthy SB, Thakur K, Kamel H.  2017.  Neurological complications after tuberculous meningitis in a multi-state cohort in the United States.. J Neurol Sci. 375:460-463.
Merkler AE, Ch'ang J, Parker WE, Murthy SB, Kamel H.  2017.  The Rate of Complications after Ventriculoperitoneal Shunt Surgery.. World Neurosurg. 98:654-658.
Merkler AE, Gialdini G, Yaghi S, Okin PM, Iadecola C, Navi BB, Kamel H.  2017.  Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.. Stroke. 48(11):3073-3077.
Melman T, Victor JD.  2016.  Robust power spectral estimation for EEG data.. J Neurosci Methods. 268:14-22.
McEwen BS, Milner TA.  2017.  Understanding the broad influence of sex hormones and sex differences in the brain.. J Neurosci Res. 95(1-2):24-39.
Mazzucco M, Mannheim W, Shetty SV, Linden JR.  2022.  CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis.. Fluids Barriers CNS. 19(1):13.
Ma Q, Yang J, Li T, Milner TA, Hempstead BL.  2015.  Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.. Neurobiol Dis. 82:466-477.
K
Kummer BR, Gialdini G, Sevush JL, Kamel H, Patsalides A, Navi BB.  2016.  External Validation of the Cincinnati Prehospital Stroke Severity Scale.. J Stroke Cerebrovasc Dis. 25(5):1270-1274.
Kummer BR, Bhave PD, Merkler AE, Gialdini G, Okin PM, Kamel H.  2015.  Demographic Differences in Catheter Ablation After Hospital Presentation With Symptomatic Atrial Fibrillation.. J Am Heart Assoc. 4(9):e002097.
Kuceyeski A, Navi BB, Kamel H, Raj A, Relkin N, Toglia J, Iadecola C, O'Dell M.  2016.  Structural connectome disruption at baseline predicts 6-months post-stroke outcome.. Hum Brain Mapp. 37(7):2587-601.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Kim E, Woo M-S, Qin L, Ma T, Beltran CD, Bao Y, Bailey JA, Corbett D, Ratan RR, Lahiri DK et al..  2015.  Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke.. J Neurosci. 35(45):15113-26.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, Min JK, Iadecola C, Gupta A.  2017.  Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis.. J Stroke Cerebrovasc Dis. 26(4):863-870.
Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MSV.  2015.  Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.. Stroke. 46(11):3208-12.